A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine ...

A multi-institutional study led by researchers at the Salk Institute for Biological Studies, UNC Lineberger Comprehensive ...

For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...

CHAPEL HILL, N.C. - Feb. 4, 2026 - A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute ...

This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8 + T cells in patients with pancreatic ductal adenocarcinoma (PDAC), ...

Research Highlights Gut Microbiome’s Role in Cancer Defense Mechanisms Gut Bacteria May Decide Whether a Dietary Amino Acid ...

First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

They discovered that an ongoing viral infection causes a brief but striking shift in the availability of nutrients in the ...

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the U.S. Food and Drug Administration (FDA) clearance of ...